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Abstract
Background:  Both  Mycobacterium tuberculosis and  Streptococcus pneumoniae are common
pathogens in patients with HIV infection.
Case Presentation: We present an unusual case of purulent pericarditis resulting in cardiac
tamponade due to infection with both organisms. We highlight the re-emergence of pneumococcal
pericarditis in the HIV era and describe the pitfalls and challenges in the diagnosis of this condition.
Conclusion: Clinicians working in HIV endemic areas need to consider dual infection with these
organisms in patients who respond inadequately to either antibiotics or anti-tuberculous therapy
alone.
Background
Streptococcus pneumoniae is a common cause of infections
of the middle ear and airways in man. In the pre-antibiotic
era, haematogenous spread to more distant sites, termed
invasive pneumococcal infection (IPI), was a major cause
of morbidity and mortality. In recent years, a resurgence
of IPI has been observed in patients with underlying
human immunodeficiency (HIV) infection [1,2]. We
describe a case of IPI, presenting as cardiac tamponade
due to purulent pericarditis, in a patient co-infected with
tuberculosis (TB) and clinical features of advanced HIV
infection.
Case history
A 33 year old man presented with a 3 week history of a
cough productive of white sputum, pleuritic type chest
pain and night sweats. More recently he had developed
swollen feet and New York Heart Association class III dys-
pnoea. He had been experiencing chronic weight loss and
generalised body weakness. He had no known TB contacts
and had no significant past medical history.
On admission, the patient was apyrexial, pale, dyspnoeic
at rest, with a blood pressure of 113/88 mmHg, a palpable
pulsus paradoxus and pulse rate 122 beats per minute.
There were signs of biventricular failure including a raised
jugular venous pressure, bibasal crackles, right pleural
effusion, 8 cm firm hepatomegaly and bilateral pedal
oedema up to the knees. Examination of the precordium
revealed a poorly palpable apex beat with soft heart
sounds and a gallop rhythm. General examination
revealed obvious stigmata of HIV infection, including
wasting, oral candidiasis, melanonychiae (blue nails) and
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generalised lymphadenopathy, including epitrochlear
nodes.
Chest x-ray on admission showed a massively enlarged
globular cardiac shadow and large right pleural effusion.
The electrocardiogram revealed a sinus tachycardia, small
QRS complexes and inverted T-waves in the precordial
leads. Initial laboratory investigations showed a normal
total white cell count of 7.17 × 109/l, with an absolute
neutrophilia of 5.43 × 109/l, haemoglobin of 9.1 g/dl and
platelet count of 327 × 109/l. His serum urea was mildly
elevated at 8.2 mmol/l with normal electrolytes. The
patient refused to consent to testing for HIV infection
despite repeated counselling. An echocardiogram per-
formed on the day after admission demonstrated a mas-
sive pericardial effusion with fibrin strands and right
ventricular systolic collapse, features consistent with a
diagnosis of cardiac tamponade (Fig. 1). Pericardiocente-
sis was performed and 950 ml of brown, purulent fluid
drained.
Despite empiric 4 drug anti-tuberculous therapy
(rifampicin, isoniazid, pyrazinamide and ethambutol),
oral prednisone (40 mg bd) and furosemide (40 mg bd),
the patient's condition worsened and he became pyrexial.
Four days post-admission, a penicillin-resistant strain of
Streptococcus pneumoniae (MIC = 0.5 ug/ml) was isolated
from the pericardial aspirate, but no acid fast bacilli were
observed on auramine stain. The patient's clinical condi-
tion improved marginally on intravenous cefotaxime, but
10 days post-admission a repeat echocardiogram showed
re-accumulation of the pericardial fluid with collapse of
the right ventricle. At this point a subxiphoid pericardiot-
omy was performed and a pericardial drain inserted. The
patient developed a left sided pleural effusion post-opera-
tively and a chest drain was inserted. A follow-up echocar-
diogram showed a thickened pericardium a small
pericardial collection (<0.5 cm), but with no evidence of
tamponade.
Because of an ongoing pyrexia and chest symptoms, chest
ultrasonagraphy was ordered which revealed bilateral loc-
ulated effusions. A chest CT scan showed supraclavicular,
mediastinal and abdominal adenopathy; residual pericar-
dial thickening and effusion; bilateral residual pleural
effusions; and patchy consolidation of the right upper
lobe. At this stage the patient refused further surgical inter-
vention and was discharged on anti-tuberculous therapy.
Culture of pericardial fluid subsequently grew Mycobacte-
rium tuberculosis.
Discussion
Historically, purulent pericarditis was seen most com-
monly as a complication of pneumonia in otherwise
healthy children and young adults [3,4]. With the advent
of antibiotics for widespread use in 1943, the condition
became rare and was confined mainly to the elderly with
serious co-morbidity. In more recent times, two cases of
HIV-1 positive, female patients with TB who developed
pneumococcal pericarditis have been reported in the
United States [5]. Our case represents an additional exam-
ple of purulent pneumococcal pericarditis in a patient
with underlying HIV infection, although the latter could
not be definitively proven. To the best of our knowledge,
there are no published reports of co-infection with TB and
pneumococcus of the pericardium from Africa. However,
Schleicher and Feldman have reported nine cases of dual
infection with these organisms presenting as community
acquired pneumonia in patients with HIV infection [6].
In most cases, purulent pneumococcal pericarditis is a
result of either direct spread or bacteraemia due to
intrathoracic diseases such as pneumonia, empyema,
myocardial abscesses or endocarditis [3,4]. The pericar-
dium is rarely a source of primary infection. A pre-existing
aseptic pericarditis is a predisposing condition in nearly
half of cases [3]. The clinical diagnosis of pneumococcal
pericarditis is often challenging and critical to make, since
the condition is fatal if left untreated [4]. In large studies,
ante-mortem diagnosis has been made, at most, in only a
fifth of all cases [3,4]. Pulsus paradoxus, where present,
has been found to be a useful diagnostic sign [4], which
was evident in our patient.
Specific defects in host defence, particularly humoral
immunity make HIV-1 seropositive individuals particu-
larly susceptible to infection with encapsulated bacteria
[2]. Contrary to the common notion, Streptococcus pneu-
moniae and not Mycobacterium tuberculosis is the common-
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est and earliest serious pathogen to cause disease during
HIV infection [1]. Furthermore, HIV infection predisposes
to penicillin-resistant strains, as in our case, which are
otherwise seen only children [7].
Tuberculosis is a common cause of pericarditis in HIV-
endemic areas and there is indirect evidence to suggest
that the outcome of tuberculous pericarditis is worse in
patients with underlying HIV infection. A recent large
multicentre study of tuberculous pericarditis from sub-
Saharan Africa has shown that, compared to otherwise
immunocompetent patients, patients with clinical HIV
infection have a greater degree of dyspnoea, haemody-
namic instability, cardiomegaly and electrocardiographic
features of myopericarditis [8].
In conclusion, this case illustrates that while TB remains
the commonest infectious cause of pericardial effusion in
sub-Saharan Africa, in the context HIV infection, pneumo-
coccal pericarditis needs to be actively excluded. Particular
attention to the cardiovascular examination should be
given in HIV positive patients with pneumococcal pneu-
monia or empyema.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
AL and MT both contributed to the clinical work-up of the
patient and writing-up of the manuscript.
Acknowledgements
The editors of this journal have accepted this case report for publication 
without written patient consent. The authors were unable to contact rela-
tives of the patient, and the editors deemed the case important enough to 
publish.
References
1. Gilks CF, Ojoo SA, Ojoo JC, Brindle RJ, Paul J, Batchelor BI, Kimari
JN, Newnham R, Bwayo J, Plummer FA, et al.: Invasive pneumococ-
cal disease in a cohort of predominantly HIV-1 infected
female sex-workers in Nairobi, Kenya.  Lancet 1996,
347:718-723.
2. Janoff EN, Breiman RF, Daley CL, Hopewell PC: Pneumococcal dis-
ease during HIV infection. Epidemiologic,  clinical, and
immunologic perspectives.  Ann Intern Med 1992, 117:314-324.
3. Klacsmann PG, Bulkley BH, Hutchins GM: The changed spectrum
of purulent pericarditis: an 86 year autopsy experience in
200 patients.  Am J Med 1977, 63:666-673.
4. Kauffman CA, Watanakunakorn C, Phair JP: Purulent pneumococ-
cal pericarditis. A continuing problem in the antibiotic era.
Am J Med 1973, 54:743-750.
5. Karve MM, Murali MR, Shah HM, Phelps KR: Rapid evolution of
cardiac tamponade due to bacterial pericarditis in two
patients with HIV-1 infection.  Chest 1992, 101:1461-1463.
6. Schleicher GK, Feldman C: Dual infection with Streptococcus
pneumoniae and Mycobacterium tubercolosis in HIV-serop-
ositive patients with community acquired pneumonia.  Int J
Tuberc Lung Dis 2003, 7:1207-120.
7. Crewe-Brown HH, Karstaedt AS, Saunders GL, Khoosal M, Jones N,
Wasas A, Klugman KP: Streptococcus pneumoniae blood cul-
ture isolates from patients with and without human immun-
odeficiency virus infection: alterations in penicillin
susceptibilities and in serogroups or serotypes.  Clin Infect Dis
1997, 25:1165-1172.
8. Mayosi BM, Wiydonge CS, Ntsekhe M, Volmink JA, Gumedze F, et al.:
Clinical characteristics and initial management of patients
with tuberculous pericarditis in the HIV era: the Investiga-
tion of the Management of Pericarditis in Africa (IMPI
Africa) registry.  BMC Infect Dis 2006, 6:2.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2334/7/12/prepub